Home › Trials › NCT06133647
Clinical trial No longer in our active list Observational Ages 18 to 85

Understanding male breast cancer at Methodist Health System

Official title: Demographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health System

Run by Methodist Health System · NCT06133647 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study looks at male breast cancer patients at Methodist Health System to learn more about their experiences and outcomes, so doctors can better understand and treat this condition.

Quick facts

Study typeObservational
Ages18 Years to 85 Years
SexAll
Enrollment8 (estimated)
SponsorMethodist Health System
Academic / other
Locations2 sites (Dallas, Texas and 1 other locations)
Trial IDNCT06133647 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are males aged 18 and older diagnosed with ductal carcinoma in situ or invasive lobular carcinoma.

Probably not a fit

Patients who are under 18, pregnant, breastfeeding, or incarcerated will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to gather data on the demographics, characteristics, and outcomes of male breast cancer patients at Methodist Health System. By focusing on cases of ductal carcinoma in situ and invasive lobular breast carcinoma, the study seeks to fill the gap in clinical data regarding male breast cancer, which is often managed based on female breast cancer data. The findings will help identify unique aspects of male breast cancer and potentially guide future treatment approaches.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and management of male breast cancer, ultimately enhancing patient outcomes.

How similar studies have gone: While male breast cancer is rare and under-researched, previous studies have indicated the need for more focused research, suggesting that this approach is novel and necessary.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* • ≥ 18 years of age Patients diagnosed with ductal carcinoma in situ or invasive lobular carcinoma of the breast

Exclusion Criteria:

* 18 years of age

  * Prisoners
  * Pregnant or breastfeeding

Where it's running

  • Clinical Research Institute at Methodist Health System
    Dallas, Texas, United States     Recruiting
  • Clinical Research Institute at Methodist Health System
    Dallas, Texas, United States     Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Ductal Carcinoma in Situ 11Invasive Lobular Breast Carcinoma 2Methodist Health System 18
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.